First Use of Maribavir in Poland to Treat Refractory CMV Disease in a Patient After Kidney Transplantation. Pawlowska A, Kwella N, Zbrzezniak-Suszczewicz J, Knysak M, et al. Transplant Proc 2025 Feb 24:S0041-1345(25)00083.

Read + Share

Amedeo Smart

Independent Medical Education

Pawlowska A, Kwella N, Zbrzezniak-Suszczewicz J, Knysak M, et al. First Use of Maribavir in Poland to Treat Refractory CMV Disease in a Patient After Kidney Transplantation. Transplant Proc 2025 Feb 24:S0041-1345(25)00083.
PMID: 40000309